SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kimberly Lee who wrote ()2/29/2000 10:45:00 AM
From: Mr. Fortune  Read Replies (2) of 108040
 
LEXINGTON, Mass., Feb. 29 /PRNewswire/ -- MacroChem Corporation (Nasdaq: MCHM ) announced today favorable results from a rodent carcinogenicity study of topically applied SEPA(R), MacroChem's proprietary excipient that enhances transdermal penetration of a variety of therapeutically useful drugs. SEPA is a registered acronym for Soft Enhancement of Percutaneous (through the skin) Absorption. Despite six months of
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News